Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT03210532
  4. Details
NCT03210532 Clinical Trial

Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia

Hypertension Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03210532
Other study ID # DW1501-301
Secondary ID
Status Completed
Phase Phase 3
First received October 12, 2016
Last updated January 30, 2018
Start date October 7, 2016
Est. completion date September 2017

Study information
Verified date January 2018
Source Daewon Pharmaceutical Co., Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A Multicenter, Randomized, Double-blinded, Double-dummy, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Treatment with DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients with Hypertension and Dyslipidemia

Recruitment information / eligibility
Status Completed
Enrollment 129
Est. completion date September 2017
Est. primary completion date September 2017
Accepts healthy volunteers No
Gender All
Age group 19 Years to 79 Years
Eligibility Inclusion Criteria:

- Adults both male and female who are =19,<80 years old

- at screening, 140mmHg= SBP<180mmHg & 90mmHg= DBP<110mmHg & LDL-C=250mg/dL & triglyceride<400mg/dL

Exclusion Criteria:

- at screening, the difference BP of one-side arm is SBP = 20mmHg and DBP = 10mmHg

- secondary hypertension or secondary dyslipidemia

- patients who have uncontrolled diabetes melitus, hyper/hypothyroidism or cardiac disease

- women who are pregnant or lactating

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Telmisartan + Amlodipine + Rosuvastatin
Telmisartan + Amlodipine + Rosuvastatin + Telmisartan placebo
• Telmisartan + Amlodipine
Telmisartan + Amlodipine + Rosuvastatin placebo + Telmisartan placebo
• Telmisartan + Rosuvastatin
Telmisartan + Amlodipine placebo + Rosuvastatin + Telmisartan placebo

Locations
Country Name City State
Korea, Republic of Sevrance Hospital Seoul

Sponsors (1)
Lead Sponsor Collaborator
Daewon Pharmaceutical Co., Ltd.

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change of MSSBP(Mean Sit Systolic Blood Pressure) from baseline 8-week
Primary Change of LDL-C(Low Density Lipid Cholesterol) from baseline 8-week
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A